Cargando…
Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation
OBJECTIVE: Recently, circulating donor-derive cell free DNA (dd-cfDNA) has gained growing attention in the field of solid organ transplantation. The aim of the study was to analyze circulating dd-cfDNA levels in graft rejection, ACR and AMR separately for each rejection type compared with non-reject...
Autores principales: | Li, Yunhui, Liang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598712/ https://www.ncbi.nlm.nih.gov/pubmed/37885888 http://dx.doi.org/10.3389/fimmu.2023.1263389 |
Ejemplares similares
-
Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation
por: Keller, Michael, et al.
Publicado: (2021) -
Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2023) -
Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study
por: Zhang, Huanxi, et al.
Publicado: (2020) -
Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation
por: Khush, Kiran K., et al.
Publicado: (2021) -
Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation
por: Tanaka, Shin, et al.
Publicado: (2018)